Fubon Bank
Fubon Bank (Hong Kong) Limited is a commercial bank that offers a comprehensive range of banking and financial services. Established in 1970 and operating as a subsidiary of Fubon Financial Holding Co., Ltd., the bank serves both retail and institutional clients through its various segments. It provides services including fixed deposits, current accounts, loans, credit cards, and mortgage products, alongside working capital and trade finance solutions. Fubon Bank also engages in securities brokerage, wealth management, and investment services, offering diverse products such as life and property insurance, as well as equity and currency-linked deposits. With a network of 22 branches and 2 securities services centers in Hong Kong, the bank maintains strong liquidity and asset quality, holding favorable ratings from Standard & Poor's.
Optimer Pharmaceuticals, Inc. (Optimer) is a biopharmaceutical company focused on discovering, developing and commercializing anti-infective products. It has two late-stage anti-infective product candidates, fidaxomicin and Pruvel (prulifloxacin). Optimer's development efforts are focused on products that treat gastrointestinal infections, and related diseases where therapies have limitations. Its product portfolio includes Fidaxomicin, Pruvel, CEM-101, OPT-822/OPT-821 Combination Therapy and OPT-88.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.